[Federal Register Volume 85, Number 38 (Wednesday, February 26, 2020)]
[Notices]
[Pages 11125-11126]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03825]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2019-0164]
Information Collection: Medical Use of Byproduct Material
AGENCY: Nuclear Regulatory Commission.
ACTION: Renewal of existing information collection; request for
comment.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public
comment on the renewal of Office of Management and Budget (OMB)
approval for an existing collection of information. The information
collection is entitled, ``Medical Use of Byproduct Material.''
DATES: Submit comments by April 27, 2020. Comments received after this
date will be considered if it is practical to do so, but the Commission
is able to ensure consideration only for comments received on or before
this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0164. For
technical questions, contact the individual listed in the FOR FURTHER
INFORMATION CONTACT section of this document.
Mail comments to: David Cullison, Office of the Chief
Information Officer, Mail Stop: T-6 A10M, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2019-0164 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0164. A copy of
the collection of information and related instructions may be obtained
without charge by accessing Docket ID NRC-2019-0164 on this website.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or
by email to [email protected]. The supporting statement and burden
spreadsheet are available in ADAMS under Accession Nos. ML19344D378 and
ML19344D379.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
NRC's Clearance Officer: A copy of the collection of
information and related instructions may be obtained without charge by
contacting NRC's Clearance Officer, David Cullison, Office of the Chief
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2084; email:
[email protected].
B. Submitting Comments
Please include Docket ID NRC-2019-0164 in your comment submission.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC will post all comment submissions at
https://www.regulations.gov as well as enter the comment submissions
into ADAMS. The NRC does not routinely edit comment submissions to
remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include
[[Page 11126]]
identifying or contact information that they do not want to be publicly
disclosed in their comment submission. Your request should state that
the NRC does not routinely edit comment submissions to remove such
information before making the comment submissions available to the
public or entering the comment into ADAMS.
II. Background
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting public comment on its intention to
request the OMB's approval for the information collection summarized
below.
1. The title of the information collection: 10 CFR part 35,
``Medical Use of Byproduct Material.''
2. OMB approval number: 3150-0010.
3. Type of submission: Extension.
4. The form number, if applicable: Not applicable.
5. How often the collection is required or requested: Reports of
medical events, doses to an embryo/fetus or nursing child, or leaking
source are reportable on occurrence. A specialty board certifying
entity desiring to be recognized by the NRC must submit a one-time
request for recognition and infrequently revise the information.
6. Who will be required or asked to respond: Physicians and medical
institutions holding an NRC license authorizing the administration of
byproduct material or radiation from this material to humans for
medical use. A specialty board certification entity desiring to have
its certifying process and board certificate recognized by NRC.
7. The estimated number of annual responses: 299,266 (292,182
reporting responses + 7,019 recordkeepers + 65 third party disclosure
responses).
8. The estimated number of annual respondents: 7,021 (856 NRC
licensees + 6,163 Agreement State licensees + 2 specialty board
certification entity).
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 1,166,694 hours (69,391
reporting + 1,097,177 recordkeeping + 127 third party disclosure).
10. Abstract: 10 CFR part 35, ``Medical Use of Byproduct
Material,'' contains NRC's requirements and provisions for the medical
use of byproduct material and for issuance of specific licenses
authorizing the medical use of this material. These requirements and
provisions provide for the radiation safety of workers, the general
public, patients, and human research subjects. Part 35 contains
mandatory requirements that apply to NRC licensees authorized to
administer byproduct material or radiation to humans for medical use.
These requirements also provide voluntary provisions for specialty
boards to apply to have their certification processes recognized by the
NRC so that their board certified individuals can use the
certifications as proof of training and experience.
II. Specific Requests for Comments
The NRC is seeking comments that address the following questions:
1. Is the proposed collection of information necessary for the NRC
to properly perform its functions? Does the information have practical
utility?
2. Is the estimate of the burden of the information collection
accurate?
3. Is there a way to enhance the quality, utility, and clarity of
the information to be collected?
4. How can the burden of the information collection on respondents
be minimized, including the use of automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 21st day of February 2020.
For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2020-03825 Filed 2-25-20; 8:45 am]
BILLING CODE 7590-01-P